HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome.

Abstract
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder with a complex phenotypic spectrum but simple biomarkers in cerebrospinal fluid. The disorder is caused by impaired glucose transport into the brain resulting from variants in SCL2A1. In 10% of GLUT1DS patients, a genetic diagnosis can not be made. Using whole-genome sequencing, we identified a de novo 5'-UTR variant in SLC2A1, generating a novel translation initiation codon, severely compromising SLC2A1 function. This finding expands our understanding of the disease mechanisms underlying GLUT1DS and encourages further in-depth analysis of SLC2A1 non-coding regions in patients without variants in the coding region.
AuthorsMichèl A Willemsen, Lisenka Elm Vissers, Marcel M Verbeek, Bregje W van Bon, Sinje Geuer, Christian Gilissen, Joerg Klepper, Michael P Kwint, Wilhelmina G Leen, Maartje Pennings, Ron A Wevers, Joris A Veltman, Erik-Jan Kamsteeg
JournalEuropean journal of human genetics : EJHG (Eur J Hum Genet) Vol. 25 Issue 6 Pg. 771-774 (06 2017) ISSN: 1476-5438 [Electronic] England
PMID28378819 (Publication Type: Journal Article)
Chemical References
  • 5' Untranslated Regions
  • Codon, Initiator
  • Glucose Transporter Type 1
  • Monosaccharide Transport Proteins
  • SLC2A1 protein, human
Topics
  • 5' Untranslated Regions
  • Adolescent
  • Carbohydrate Metabolism, Inborn Errors (diagnosis, genetics)
  • Cells, Cultured
  • Codon, Initiator (genetics)
  • Female
  • Glucose Transporter Type 1 (genetics, metabolism)
  • Humans
  • Monosaccharide Transport Proteins (deficiency, genetics)
  • Mutation
  • Peptide Chain Initiation, Translational

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: